Muscle Recovery and Fatigue
Multipotency of Hematopoietic Stem Cells
Somatic to iPS Cell Reprogramming
Tissue Renewal without Stem Cells
Chromatin Modification in iPS Cells
Maintenance of the ES Cell State
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 10, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
Evan W Weber1, Kevin R Parker2, Elena Sotillo1
1Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
Resting chimeric antigen receptor (CAR)-T cells can reverse exhaustion, a key barrier in cancer immunotherapy. This approach restores antitumor function and enhances CAR-T cell efficacy, challenging the idea that exhaustion is permanent.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: